3 Dirt-Cheap Stocks With Massive Upside — One Big Name Might Surprise You

Key Concepts

• Small-Cap Stocks: Companies with smaller market capitalizations, often overlooked during high-interest-rate environments but potentially poised for significant growth during market turnarounds.
• Price-to-Earnings (P/E) Ratio: A valuation metric used to determine if a stock is cheap or expensive relative to its earnings. The speaker targets a range of 5x to 12x, significantly lower than the S&P 500 average of 21x–22x.
• Falling Knife: A market term for a stock that is rapidly declining in price; investors are often cautioned against buying these until the downward momentum stabilizes.
• Royalty-Based Business Model: A strategy where a company generates revenue from intellectual property (e.g., drug patents) without needing to manufacture or market the end product themselves.
• Binary Bet: An investment scenario where the outcome is highly dependent on a specific upcoming event (e.g., an earnings report or regulatory approval), leading to potentially sharp price movements in either direction.

1. Market Context: The Case for Small Caps

The speaker argues that small-cap stocks have been "dead money" for several years due to high interest rates and market headwinds favoring large-cap names. However, analysts suggest that if the broader market experiences a significant rally, small caps are likely to lead the way because they are currently "beaten down" and offer high value relative to their earnings.

2. Featured Small-Cap Stocks

A. Innoviva (INVA) – Biotech

• Business Model: Innoviva partners with GlaxoSmithKline to collect royalties on respiratory treatments. This provides a steady revenue stream to fund their own pipeline of critical care and infectious disease therapeutics.
• Financials: Trading at a P/E ratio of approximately 7.8x. The company is profitable and projected to see over 360% earnings growth this year.
• Key Metric: Dependence on royalty income is decreasing (from 72% to 60%), signaling a transition toward becoming a self-sustaining commercial entity.
• Outlook: Consensus price target is $34.80, representing over 45% upside.

B. Neighbors Industries (NBR) – Oil & Gas Drilling

• Business Model: Provides drilling services for oil and gas companies. Their business accelerates when oil prices make increased production cost-efficient.
• Financials: Trading at a P/E ratio of approximately 5x.
• Catalysts: Recent earnings beats were driven by strategic acquisitions and debt reduction. The stock has also benefited from rising oil prices due to geopolitical tensions (e.g., the Iran conflict).
• Risk/Reward: The speaker notes that while oil prices could drop if geopolitical tensions ease, long-term global energy demand (driven by infrastructure and data centers) provides a structural tailwind.
• Analyst Sentiment: Despite trading above consensus, firms like Citigroup and Susquehanna have recently raised price targets to $89 and $85, respectively.

C. Wendy’s (WEN) – Restaurant/Retail

• Business Model: A fast-food chain currently facing significant headwinds, including same-store sales declines and consumer pullbacks.
• Financials: Trading at a P/E of 8.3x (forward P/E of 7.1x).
• The "Falling Knife" Argument: The speaker acknowledges the stock is "so bad it’s finally good." Management is focusing on "controlling the controllables," such as closing underperforming locations.
• Dividend: Offers a dividend yield of approximately 7.9%, which serves as a primary incentive for investors while waiting for a potential turnaround.
• Growth Projection: Analysts project 13% earnings growth for the year, which is high compared to the low single-digit growth typical of the restaurant sector.

3. Methodologies and Risk Management

• Valuation Screening: The speaker filters for stocks with a P/E ratio between 5x and 12x to identify deep value.
• Risk Assessment:
  • Biotech: The primary risk is clinical trial failure or lack of FDA approval, which can halt revenue growth.
  • Oil & Gas: The primary risk is the volatility of commodity prices and geopolitical resolution.
  • Retail/Turnaround: The primary risk is "selling begets selling," where negative sentiment keeps the stock price depressed regardless of fundamental improvements.
• Actionable Advice: Investors are encouraged to monitor upcoming earnings reports (specifically for Neighbors Industries on April 29th) as these serve as "binary" catalysts that will dictate future price action.

4. Synthesis and Conclusion

The core thesis presented is that investors can find significant upside in small-cap stocks by looking for companies that are fundamentally sound but currently trading at a deep discount to the S&P 500. While these stocks carry inherent risks—ranging from clinical trial outcomes in biotech to geopolitical volatility in energy and consumer demand shifts in retail—the potential for earnings growth and high dividend yields makes them compelling candidates for a watch list. The speaker emphasizes that investors should focus on management's ability to control internal operations (like debt reduction or store closures) rather than relying solely on external market conditions.